CIK 0001341235 · Non-accelerated filer<br>Smaller reporting company
Aldeyra Therapeutics, Inc.
Sign in to watch- Ticker
- ALDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-761-4904
- Business address
- 23 BRADFORD STREET, SUITE 1, CONCORD, MA, 01742
- Former names
- Aldexa Therapeutics, Inc., Neuron Systems Inc
- 4 Open-market buy Director bought 1,000 shares at $3.95 ($3,948)
- 4 Open-market buy Director bought 3,000 shares at $3.69 ($11,059)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Other events
- 8-K Event Executive or director change
- S-8 Other Securities Offered to Employees in Benefit Plans
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 6,250 shares at $8.00 ($50,000)
- 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
- 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
- 4 Open-market buy President and CEO bought 12,500 shares at $8.00 ($100,000)
- 4 Open-market buy Director bought 9,375 shares at $8.00 ($75,000)
- 4 Open-market buy Director bought 12,500 shares at $8.00 ($100,000)
- 8-K Event Regulation FD disclosure
- 8-K Event Bylaws or fiscal year change
Page 30 of 33 · 650 filings